Angiogenex Inc

(AGGX)

By |

Profile

AngioGenex Inc is a United States-based biopharmaceutical company. It is dedicated to the development and commercialization of a novel, inexpensive treatment for vascular diseases including many forms of cancer and macular degeneration. Its lead drug candidates include AGX51 and several other proprietary small molecules that have shown specific activity in various animal models of various cancers and macular degeneration. Further, it also focuses on developing Id-inhibitor drugs to treat cancer and macular degeneration. Geographically, the activities are carried out through the region of the United States.

Contact Information

Website: www.angiogenex.com
Main Phone: +1 347 468-6799
Address: 425 Madison Avenue
Address 2: Suite 902
State: NY
City / Town: New York
Country: USA
Postal Code: 10017

Issuer Information

Exchange: OTO
CEO: William A. Garland
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.23 $ 0. (0.00%)
Last Price 0.23 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.23
Last Trade Volume 0 52 Wk Hi 0.40 52 Wk Low 0.11
Market Cap 6.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 29,386,667.00 EPS (TTM) -0.02 PE Ratio N/A Exchange OTCPK